What are syphilis tests?
Syphilis tests are used to screen for and diagnose syphilis. Syphilis is one of the most common sexually transmitted diseases (STDs). It is a bacterial infection that spreads through vaginal, oral, or anal sexual contact with someone who has the infection. It can also pass from a pregnant person to their baby.
Syphilis usually develops in stages. Each stage has different signs and symptoms that can last for weeks, months, or even years. In the beginning, the signs and symptoms may be mild. You may not notice them. So, you could have syphilis and not know it. You could pass the infection to someone else.
Syphilis is easiest to cure in the early stages of infection. If it's not treated and develops to a late stage, it can cause permanent damage to your health. Treatment can still help, but it will not reverse the damage. In rare cases, untreated syphilis can even cause death.
Syphilis tests can help diagnose the infection in the early stages, when it's easiest to cure. Finding and treating the infection early can also prevent the spread of syphilis to others.
What are they used for?
Syphilis tests screen for and diagnose syphilis by looking for certain antibodies in your blood. Antibodies are proteins that your immune system makes when it finds harmful substances in your body.
Syphilis testing usually involves two steps. In most cases, the first step is a screening test to check for antibodies that are linked to having a syphilis infection. But other things may trigger your immune system to make these antibodies, such as autoimmune diseases, other infections, and vaccinations.
The LYHER® Syphilis Rapid Test is a lateral flow, serological, immunochromatographic assay for the qualitative detection of IgG or IgM antibodies to Treponema Pallidum (TP) in human whole blood, serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with TP. Any reactive specimen with the Syphilis Rapid Test must be confirmed with alternative testing method(s) and clinical findings.
Post time: Sep-16-2022